Cited by 2,020Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisOccupational and environmental lung diseasesPulmonary Hypertension Research and Treatments

The DOI matches its Crossref record; 141 of the 143 references it cites were found in a registry or an index.

Idiopathic pulmonary fibrosis

Richeldi, Luca, Collard, Harold R, Jones, Mark G·2017·The Lancet

DOI 10.1016/s0140-6736(17)30866-8

Open this paper in CoChat — free account

Abstract

Idiopathic pulmonary fibrosis is a prototype of chronic, progressive, and fibrotic lung disease. Healthy tissue is replaced by altered extracellular matrix and alveolar architecture is destroyed, which leads to decreased lung compliance, disrupted gas exchange, and ultimately respiratory failure and death. In less than a decade, understanding of the pathogenesis and management of this disease has been transformed, and two disease-modifying therapies have been approved, worldwide. In this Seminar, we summarise the presentation, pathophysiology, diagnosis, and treatment options available for patients with idiopathic pulmonary fibrosis. This disease has improved understanding of the mechanisms of lung fibrosis, and offers hope that similar approaches will transform the management of patients with other progressive fibrotic lung diseases.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(17)30866-8

Cites

141 of 141 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cancer Incidence in Five Continents
Doll, R., Muir, C. S., & Waterhouse, J. A. H. (1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,485
An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Self-citation
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Self-citation
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
Travis, W. D., Costabel, U., Hansell, D. M., King, T. E., Lynch, D. A., Nicholson, A. G., Ryerson, C. J., Ryu, J. H., Selman, M., Wells, A. U., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201308-1483st · Cited by 4,378
Self-citation
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Fleischner Society: Glossary of Terms for Thoracic Imaging
Hansell, D. M., Bankier, A. A., MacMahon, H., McLoud, T. C., Müller, N. L., & Rémy, J. (2008) · Radiology · doi:10.1148/radiol.2462070712 · Cited by 4,189
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,651
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Noble, P. W., Albera, C., Bradford, W. Z., Costabel, U., Glassberg, M. K., Kardatzke, D., King, T. E., Lancaster, L., Sahn, S. A., Szwarcberg, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60405-4 · Cited by 2,154
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice Guideline
Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916
Self-citation

Show all 143 references

Research works printed but not linked: 1

2000, Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS), Am J Respir Crit Care Med, 161, 646, 10.1164/ajrccm.161.2.ats3-00 · DOI

Sorted by citations

Items 701–800 of 1,003

Weighted Gene Coexpression Network Analysis Identifies Key Genes and Pathways Associated with Idiopathic Pulmonary Fibrosis
Wang, Z., Zhu, J., Chen, F., & Ma, L. (2019) · Medical Science Monitor · doi:10.12659/msm.916828 · Cited by 17
Design, synthesis and discovery of 2(1H)-quinolone derivatives for the treatment of pulmonary fibrosis through inhibition of TGF-β/smad dependent and independent pathway
Xue, L., Deng, D., Zheng, S., Tang, M., Yang, Z., Pei, H., Chen, Y. X., Yang, T., Liu, K., Ye, H., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112259 · Cited by 18
Prolonged distribution of aerosolized PEGylated liposomes in the lungs of mice with bleomycin-induced pulmonary fibrosis
Togami, K., Maruta, Y., Nanbu, M., Tada, H., & Chono, S. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1825473 · Cited by 19
VEGF/Src signaling mediated pleural barrier damage and increased permeability contributes to subpleural pulmonary fibrosis
Lu, Y., Liang, L., Cheng, P., Xiong, L., Wang, M., Song, L., Yu, F., He, X., Xiong, L., Wang, X., et al. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00436.2020 · Cited by 18
Mortality and Respiratory-Related Hospitalizations in Idiopathic Pulmonary Fibrosis Not Treated With Antifibrotics
Cottin, V., Spagnolo, P., Bonniaud, P., Nolin, M., Dalon, F., Kirchgässler, K.-U., Kamath, T. V., Ganse, E. H. V., & Belhassen, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.802989 · Cited by 18
Network Pharmacology and Experimental Assessment to Explore the Pharmacological Mechanism of Qimai Feiluoping Decoction Against Pulmonary Fibrosis
Yang, Y., Ding, L., Bao, T., Li, Y., Ma, J., Li, Q., Gao, Z., Song, S., Wang, J., Zhao, J., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.770197 · Cited by 18
Monocyte count and the risk for acute exacerbation of fibrosing interstitial lung disease: A retrospective cohort study
Kawamura, K., Ichikado, K., Anan, K., Yasuda, Y. U., Sekido, Y., Suga, M., Ichiyasu, H., & Sakagami, T. (2020) · Chronic Respiratory Disease · doi:10.1177/1479973120909840 · Cited by 20
Comorbidities in the idiopathic pulmonary fibrosis and progressive pulmonary fibrosis trial population: a systematic review and meta-analysis
Walters, T. M., Leong, M. C. H., Montesi, S. B., Ryerson, C. J., & Khor, Y. H. (2025) · European Respiratory Review · doi:10.1183/16000617.0238-2024 · Cited by 19
Visualizing pulmonary pathologies using smart molecular fluorescent probes
Ruan, Z., Yue, L., Liu, B., Kim, E., Chen, X., Li, J., Jang, H., Lin, Z., Li, M., Peng, X., et al. (2025) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2025.217025 · Cited by 17
Wogonoside inhibits fibroblast activation and pulmonary fibrosis by dual regulation of Snail1 lactylation and PGC1α/PINK1-mediated mitophagy
Wu, J., Li, Y., yang, Y., Chen, R., Wang, H., Xie, K., Lan, J., Guo, M., Zhang, Y., & Li, X. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157240 · Cited by 17
A New Dyspnea Evaluation System Focusing on Patients’ Perceptions of Dyspnea and Their Living Disabilities: The Linkage between COPD and Frailty
Oishi, K., Matsunaga, K., Harada, M., Suizu, J., Murakawa, K., Chikumoto, A., Ohteru, Y., Matsuda, K. M., Uehara, S., Hamada, K., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113580 · Cited by 17
Inhibiting Fibroblast Mechanotransduction Modulates Severity of Idiopathic Pulmonary Fibrosis
Trotsyuk, A. A., Chen, K., Kwon, S. H., Ma, K., Henn, D., Mermin-Bunnell, A. M., Mittal, S., Padmanabhan, J., Larson, M. R., Steele, S. R., et al. (2021) · Advances in Wound Care · doi:10.1089/wound.2021.0077 · Cited by 17
Sine oculis homeobox homolog 1 plays a critical role in pulmonary fibrosis
Wilson, C., Mertens, T. C. J., Shivshankar, P., Bi, W., Collum, S. D., Wareing, N. E., Ko, J., Weng, T., Naikawadi, R. P., Wolters, P. J., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.142984 · Cited by 18
Screening for Inhibitors of YAP Nuclear Localization Identifies Aurora Kinase A as a Modulator of Lung Fibrosis
Yang, Y., dos Santos, D. M., Pantano, L., Knipe, R. S., Abe, E. A., Logue, A., Pronzati, G., Black, K. E., Spinney, J. J., Giacona, F. L., et al. (2022) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0428oc · Cited by 20
Towards an artificial human lung: modelling organ-like complexity to aid mechanistic understanding
Humbert, M. V., Spalluto, C. M., Bell, J., Blume, C., Conforti, F., Davies, E. R., Dean, L. S. N., Elkington, P. T., Haitchi, H. M., Jackson, C. L., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.00455-2022 · Cited by 21
Self-citation
Destructive fibrotic teamwork: how both microenvironment stiffness and profibrotic interleukin 13 impair alveolar macrophage phenotype and function
Bomb, K., Pradhan, L., Zhang, Q., Jarai, B. M., Bhattacharjee, A., Burris, D. L., Kloxin, A. M., & Fromen, C. A. (2022) · Biomaterials Science · doi:10.1039/d2bm00828a · Cited by 18
Genetics in Idiopathic Pulmonary Fibrosis: A Clinical Perspective
Papiris, S. A., Kannengiesser, C., Borie, R., Kolilekas, L., Kallieri, M., Apollonatou, V., Ba, I., Nathan, N., Bush, A., Griese, M., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12122928 · Cited by 18
Tanreqing injection protects against bleomycin-induced pulmonary fibrosis via inhibiting STING-mediated endoplasmic reticulum stress signaling pathway
Deng, J.-L., He, Y.-Q., Sun, G., Yang, H. J., Wang, L., Tao, X., & Chen, W. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.116071 · Cited by 17
A novel quantification method of lung fibrosis based on Micro-CT images developed with the optimized pulmonary fibrosis mice model induced by bleomycin
Yang, X., Huang, X., Chen, Z., Xu, A.-L., Zhou, H., Bi, X., Yan, P., & Xie, Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13598 · Cited by 17
Imaging of Pulmonary Fibrosis: An Update, From the AJR Special Series on Imaging of Fibrosis
Lee, K. S., Han, J., Wada, N., Hata, A., Lee, H. Y., Yi, C.-A., Hino, T., Doyle, T. J., Franquet, T., & Hatabu, H. (2023) · American Journal of Roentgenology · doi:10.2214/ajr.23.29119 · Cited by 17
Early Detection and Staging of Lung Fibrosis Enabled by Collagen-Targeted MRI Protein Contrast Agent
Ibhagui, O. Y., Li, D., Han, H., Peng, G., Meister, M. L., Gui, Z., Qiao, J., Salarian, M., Dong, B., Yuan, Y., et al. (2023) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.3c00023 · Cited by 17
Chemical components in cultivated Cordyceps sinensis and their effects on fibrosis
Dong, Z., & Sun, X. Y. (2023) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2022.11.008 · Cited by 17
Drug therapies for treatment of idiopathic pulmonary fibrosis: a systematic review, Bayesian network meta-analysis, and cost-effectiveness analysis
Zhao, C., Yin, Y., Zhu, C., Zhu, M., Ji, T., Li, Z., & Cai, J. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102071 · Cited by 18
Inhalable dry powder containing lipid polymer hybrid nanoparticles of Nintedanib esylate: In vitro and in vivo evaluations
Patel, M., Karampuri, S., Kansara, V., & Vyas, B. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104716 · Cited by 17
Astragaloside IV inhibits epithelial-mesenchymal transition and pulmonary fibrosis via lncRNA-ATB/miR-200c/ZEB1 signaling pathway
Guan, Y., Zhang, J., Cai, X., Cai, Y., Song, Z., Huang, Y., Qian, W., Pan, Z., & Zhang, X. (2023) · Gene · doi:10.1016/j.gene.2023.148040 · Cited by 17
Standigm ASK™: knowledge graph and artificial intelligence platform applied to target discovery in idiopathic pulmonary fibrosis
Han, S., Lee, J. E., Kang, S., So, M., Jin, H. K., Lee, J. H., Baek, S., Jun, H., Kim, T. Y., & Lee, Y. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae035 · Cited by 17
The Role of Lung Microbiome in Fibrotic Interstitial Lung Disease—A Systematic Review
Puiu, R., Motoc, N. Ş., Lucaciu, S.-R., Ruta, M. V., Râjnoveanu, R., Todea, D. A., & Man, M. A. (2024) · Biomolecules · doi:10.3390/biom14030247 · Cited by 18
Astragaloside IV inhibits idiopathic pulmonary fibrosis through activation of autophagy by miR-21-mediated PTEN/PI3K/AKT/mTOR pathway
Li, T., Gao, X., Jia, R., Sun, Y., Ding, Y., Wang, F., & Wang, Y. (2024) · Cellular and Molecular Biology · doi:10.14715/cmb/2024.70.2.18 · Cited by 18
Bioinformatics analysis based on extracted ingredients combined with network pharmacology, molecular docking and molecular dynamics simulation to explore the mechanism of Jinbei oral liquid in the therapy of idiopathic pulmonary fibrosis
Han, X., Zhang, A., Meng, Z., Wang, Q., Liu, S., Wang, Y., Tan, J., Guo, L., & Li, F. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38173 · Cited by 17
Drug discovery and development in idiopathic pulmonary fibrosis: the changing landscape
Cruwys, S., Hein, P., Humphries, B., & Black, D. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104207 · Cited by 18
Imaging biomarkers and staging in IPF
Walsh, S. L. F. (2018) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000507 · Cited by 18
Critical appraisal of the quality of clinical practice guidelines for idiopathic pulmonary fibrosis
Li, X., Yu, X., Xie, Y., Feng, Z., Ma, Y., Chen, Y., & Li, J. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-3200 · Cited by 17
Antifibrotic drugs in lung transplantation and chronic lung allograft dysfunction: a review
Bos, S., Sadeleer, L. D., Vanstapel, A., Beeckmans, H., Sacreas, A., Yserbyt, J., Wuyts, W. A., & Vos, R. (2021) · European Respiratory Review · doi:10.1183/16000617.0050-2021 · Cited by 20
Mortality Associated with Idiopathic Pulmonary Fibrosis in Northeastern Italy, 2008–2020: A Multiple Cause of Death Analysis
Marcon, A., Schievano, E., & Fedeli, U. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18147249 · Cited by 17
Dynamic Observation of Autophagy and Transcriptome Profiles in a Mouse Model of Bleomycin-Induced Pulmonary Fibrosis
Wang, Y., Hu, S., Shen, L., Liu, S., Wan, L., Yang, S., Hou, M., Tian, X., Zhang, H., & Xu, K. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.664913 · Cited by 17
Cabozantinib ameliorates lipopolysaccharide-induced lung inflammation and bleomycin--induced early pulmonary fibrosis in mice
Li, X., Ma, L., Wei, Y., Gu, J., Liang, J., Li, S., Cui, Y., Liu, R., Huang, H. F., Yang, C., et al. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108327 · Cited by 17
Total flavonoids of Oxytropis falcata Bunge have a positive effect on idiopathic pulmonary fibrosis by inhibiting the TGF-β1/Smad signaling pathway
Li, X., Wang, X., Wang, Y., Liang, Q., Li, Y., Chen, Y.-W., & Ming, H. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114858 · Cited by 17
Ginkgolic acid improves bleomycin‐induced pulmonary fibrosis by inhibiting SMAD4 SUMOylation
Yu, L., Bian, X., Zhang, C., Wu, Z., Huang, N., Yang, J., Jin, W., Feng, Z., Li, D., Huo, X., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/8002566 · Cited by 17
Human pluripotent stem cell-derived macrophages and macrophage-derived exosomes: therapeutic potential in pulmonary fibrosis
Rasaei, R., Tyagi, A., Rasaei, S., Lee, S., Yang, S., Kim, K.-S., Ramakrishna, S., & Hong, S. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03136-z · Cited by 18
Calpain-1 Up-Regulation Promotes Bleomycin-Induced Pulmonary Fibrosis by Activating Ferroptosis
wei, S., Liu, Y., Ran, C., Li, Y., Tang, B., Lu, M., & Wang, H. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.09.004 · Cited by 17
Single-cell transcriptome analysis revealing mechanotransduction via the Hippo/YAP pathway in promoting fibroblast-to-myofibroblast transition and idiopathic pulmonary fibrosis development
Lu, J., Wang, Z., & Zhang, L. (2025) · Gene · doi:10.1016/j.gene.2025.149271 · Cited by 16
Fibrocartilage hyalinization: A potential therapeutic strategy for articular fibrocartilage
Li, J., Jiang, H., Tan, G., Lv, Z., Liu, Z., Guo, H., Sun, Z., Xu, X., & Shi, D. (2025) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2025.04.013 · Cited by 18
Air pollution and alveolar health
Sofia, C., Parkin, J., Bell, J. A., Dean, L. S. N., Edgeway, L. J., Sayer, L. N., Easton, N. H. C., Davies, D. E., Marshall, B. G., Holgate, S. T., et al. (2025) · European Respiratory Review · doi:10.1183/16000617.0280-2024 · Cited by 20
Self-citation
Patients’ and healthcare professionals’ perspectives on the idiopathic pulmonary fibrosis care journey: a qualitative study
Delameillieure, A., Dobbels, F., Vandekerkhof, S., & Wuyts, W. A. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01431-8 · Cited by 16
Multi-Pharmaceutical Activities of Chinese Herbal Polysaccharides in the Treatment of Pulmonary Fibrosis: Concept and Future Prospects
Wu, X., Huang, J., Wang, J., Xu, Y., Yang, X., Sun, M., & Shi, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.707491 · Cited by 16
The effects and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis: a meta-analysis and systematic review
Zang, C., Zheng, Y., Wang, Y., & Li, L. (2021) · European journal of medical research · doi:10.1186/s40001-021-00601-y · Cited by 19
The efficacy and safety of pinocembrin in a sheep model of bleomycin-induced pulmonary fibrosis
Derseh, H. B., Goodger, J. Q. D., Scheerlinck, J. Y., Samuel, C. S., Woodrow, I. E., Palombo, E. A., Cumming, A., & Snibson, K. J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260719 · Cited by 16
Treating Pulmonary Fibrosis with Non-Viral Gene Therapy: From Bench to Bedside
Huang, T., Gao, J. L., Cai, L., Xie, H., Wang, Y., Wang, Y., & Zhou, Q. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040813 · Cited by 15
Disturbance of serum lipid metabolites and potential biomarkers in the Bleomycin model of pulmonary fibrosis in young mice
Yang, X., Wang, F., Chi, X., Wang, X.-M., Cong, J., Hu, Y., & Zhang, Y. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-01972-6 · Cited by 16
Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantation
Pugnet, G., Petermann, A., Collot, S., Otal, P., Lansiaux, P., Abdallah, N. A., Lorillon, G., Resche‐Rigon, M., Borel, C., Marjanovic, Z., et al. (2022) · Rheumatology · doi:10.1093/rheumatology/keac319 · Cited by 17
Rectal administration of butyrate ameliorates pulmonary fibrosis in mice through induction of hepatocyte growth factor in the colon via the HDAC-PPARγ pathway
Zhang, W., Zhang, Q., Zhu, Y., Zhang, Y., Xia, Y., Wei, Z., & Dai, Y. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120972 · Cited by 17
Pulmonary hazard identifications of Graphene family nanomaterials: Adverse outcome pathways framework based on toxicity mechanisms
Ding, X., Pu, Y., Tang, M., & Zhang, T. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.159329 · Cited by 17
Enhanced secretion of hepatocyte growth factor in human umbilical cord mesenchymal stem cells ameliorates pulmonary fibrosis induced by bleomycin in rats
Chen, H., Luo, Y., Zhu, Y., Ye, Y., Chen, D., Song, X., Xiao, Z., Liu, M., & Li, S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1070736 · Cited by 15
Is pulmonary fibrosis a precancerous disease?
Hosseini, M., & Salvatore, M. M. (2023) · European Journal of Radiology · doi:10.1016/j.ejrad.2023.110723 · Cited by 16
The role of interleukin -1 family in fibrotic diseases
Wang, H., Wu, J., Li, M., Bai, Y., & Liu, J. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156161 · Cited by 16
Anthelmintic nitazoxanide protects against experimental pulmonary fibrosis
Chen, X., Dong, Y., Yu, Y., Jiang, M., Bu, W., Li, P., Sun, Z., & Dong, D. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16190 · Cited by 17
The Role of Osteopontin in Respiratory Health and Disease
Barkas, G. I., & Kotsiou, O. S. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13081259 · Cited by 16
Vitamin D and idiopathic pulmonary fibrosis: a two-sample mendelian randomization study
Lin, T., Zhou, F., Mao, H., Xie, Z., & Jin, Y. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02589-z · Cited by 16
The role of vasoactive intestinal peptide in pulmonary diseases
Zhong, H.-L., Li, P.-Z., Li, D., Guan, C., & Zhou, Y. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122121 · Cited by 16
MiR-148a-3p within HucMSC-Derived Extracellular Vesicles Suppresses Hsp90b1 to Prevent Fibroblast Collagen Synthesis and Secretion in Silica-Induced Pulmonary Fibrosis
Jiang, Q., Zhao, J., Jia, Q., Wang, H., Xue, W., Ning, F., Wang, J., Wang, Y., Zhu, Z., & Tian, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914477 · Cited by 16
Circulating inflammatory cytokines and risk of idiopathic pulmonary fibrosis: a Mendelian randomization study
Jia, Q., Lei, Y., Chen, S., Liu, S., Wang, T., & Cheng, Y. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02658-3 · Cited by 17
Idiopathic pulmonary fibrosis-specific Bayesian network integrating extracellular vesicle proteome and clinical information
Tomoto, M., Mineharu, Y., Sato, N., Tamada, Y., Itoh, M. N., Kuroda, M., Adachi, J., Takeda, Y., Mizuguchi, K., Kumanogoh, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-023-50905-8 · Cited by 16
Caffeic acid ethanolamide induces antifibrosis, anti-inflammatory, and antioxidant effects protects against bleomycin-induced pulmonary fibrosis
Huang, C.-W., Lee, S.-Y., Du, C.-X., Wu, S.-T., Kuo, Y., & Ku, H.-C. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116298 · Cited by 18
Assessment of progression of pulmonary fibrosis based on metabonomics and analysis of intestinal microbiota
Liu, J.-Q., Zhou, H.-B., Bai, W., Wang, J., Li, Q., Fan, L., Chang, H. S., & Shi, S. (2024) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2024.2326616 · Cited by 16
A Step towards understanding coronary artery disease: a complication in idiopathic pulmonary fibrosis
Sinha, R., Nanavaty, D., AZHAR, A., Devarakonda, P. K., Singh, S., Garikipati, R., Sanghvi, A., Manoharan, S., Parhar, G., Zaman, K., et al. (2024) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2023-001834 · Cited by 16
Antifibrotic treatment adherence, efficacy and outcomes for patients with idiopathic pulmonary fibrosis in Spain: a real-world evidence study
Ortíz, A. D. R., Jiménez-Rodríguez, B. M., Ramírez, C. L., López-Bauzá, Á., Perez-Morales, M. D., Delgado-Torralbo, J. A., Moral, C. V., & Navarrete, B. A. (2024) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2023-001687 · Cited by 18
Pulmonary fibroblast-specific delivery of siRNA exploiting exosomes-based nanoscaffolds for IPF treatment
Lu, H., Liu, X., Zhang, M., Bera, H., Xu, W., Jiang, H., Zhao, X., Wu, L., Cun, D., & Yang, M. (2024) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2024.100929 · Cited by 17
Novel insights into the GCN2 pathway and its targeting. Therapeutic value in cancer and lessons from lung fibrosis development
Piecyk, M., Ferraro‐Peyret, C., Laville, D., Perros, F., & Chaveroux, C. (2024) · FEBS Journal · doi:10.1111/febs.17203 · Cited by 19
Endogenous LXR signaling controls pulmonary surfactant homeostasis and prevents lung inflammation
Hernández, I., de la Rosa, J. V., Martin‐Rodríguez, P., Díaz-Sarmiento, M., Recio, C., Guerra, B., Fernández‐Pérez, L., León, T. E., Torres, R., Font-Díaz, J., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05310-3 · Cited by 16
Evaluating the impact of type 2 diabetes mellitus on pulmonary vascular function and the development of pulmonary fibrosis
Mzimela, N., Dimba, N. R., Sosibo, A. M., & Khathi, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1431405 · Cited by 17
Mitochondrial dynamics in pulmonary disease: Implications for the potential therapeutics
Li, H., Dai, X., Zhou, J.-F., Wang, Y., Zhang, S., Guo, J., Shen, L., Yan, H., & Jiang, H. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31370 · Cited by 19
Outcomes and predictors of progression in progressive pulmonary fibrosis
Cen, Z., Cen, T., Ding, Q., Zhang, Y., Tang, P., Lv, C., & Wu, T. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2406439 · Cited by 16
Modeling and multiscale characterization of the quantitative imaging based fibrosis index reveals pathophysiological, transcriptome and proteomic correlates of lung fibrosis induced by fractionated irradiation
Zhou, C., Moustafa, M., Cao, L., Kriegsmann, M., Winter, M., Schwager, C., Jones, B., Wang, S., Bäuerle, T., Zhou, P., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.32059 · Cited by 16
Inhibitory effects of alkaline extract from the pericarp of Citrus reticulata Blanco on collagen behavior in bleomycin-induced pulmonary fibrosis
Li, R., Chen, X., Xu, Y., Feng, F., He, H., & Zhou, X. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.113761 · Cited by 16
Idiopathic pulmonary fibrosis patients with severe physiologic impairment: characteristics and outcomes
Pastré, J., Barnett, S. D., Ksovreli, I., Taylor, J., Brown, A. W., Shlobin, O. A., Ahmad, K., Khangoora, V. S., Aryal, S., King, C. S., et al. (2021) · Respiratory Research · doi:10.1186/s12931-020-01600-z · Cited by 17
Ticagrelor Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by the Inhibition of TGF-β1/Smad3 and PI3K/AKT/mTOR Pathways
Wanas, H., Shereef, Z. E., Rashed, L. A., & Aboulhoda, B. E. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210204212533 · Cited by 16
Comparison of Pharmacokinetics and Anti-Pulmonary Fibrosis-Related Effects of Sulforaphane and Sulforaphane N-acetylcysteine
Son, E. S., Fei, X., Yoon, J., Seo, S., Maeng, H., Jeong, S. H., & Kim, Y. C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13070958 · Cited by 16
Barbaloin attenuates pulmonary fibrosis through TGF-β1/Smads/p38 pathway
Zhang, G., Bai, R., Huang, J., Gao, Y., Yun, X., & Aisa, H. A. (2022) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgac023 · Cited by 16
Genetic association of telomere length, obesity and tobacoo smoking with idiopathic pulmonary fibrosis risk
Wu, W., Li, C., Zhu, X., Liu, X., Li, P., Wan, R., Wu, X., & Chen, S. (2023) · BMC Public Health · doi:10.1186/s12889-023-15733-5 · Cited by 17
Deletion of SMARCA4 impairs alveolar epithelial type II cells proliferation and aggravates pulmonary fibrosis in mice
Peng, D.-Y., Si, D., Zhang, R., Liu, J., Gou, H., Xia, Y., Tian, D., Dai, J., Yang, K., Liu, E., et al. (2017) · Genes & Diseases · doi:10.1016/j.gendis.2017.10.001 · Cited by 16
Delineation of the healthy rabbit kidney by immunohistochemistry – A technical note
Bürgisser, G. M., Heuberger, D. M., Giovanoli, P., Calcagni, M., & Buschmann, J. (2021) · Acta Histochemica · doi:10.1016/j.acthis.2021.151701 · Cited by 16
Fibrosis‐on‐Chip: A Guide to Recapitulate the Essential Features of Fibrotic Disease
Streutker, E. M., Devamoglu, U., Vonk, M. C., Verdurmen, W. P. R., & Gac, S. L. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303991 · Cited by 15
PLAC8 attenuates pulmonary fibrosis and inhibits apoptosis of alveolar epithelial cells via facilitating autophagy
Sun, W., Zhao, B., He, Z., Chang, L., Song, W., & Chen, Y. (2025) · Communications Biology · doi:10.1038/s42003-024-07334-8 · Cited by 15
Idiopathic Pulmonary Fibrosis: Cellular Heterogeneity, Mechanisms, and Therapeutic Implications
Zuo, L., Liu, Q., Ye, D., Fan, J., & Wu, L. (2025) · MedComm · doi:10.1002/mco2.70521 · Cited by 17
Investigational drugs for idiopathic pulmonary fibrosis
Varone, F., Montemurro, G., Macagno, F., Calvello, M., Conte, E. G., Intini, E., Iovene, B., Leone, P. M., Mari, P., & Richeldi, L. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1364361 · Cited by 15
Self-citation
Pulmonary fibrosis in Fra-2 transgenic mice is associated with decreased numbers of alveolar macrophages and increased susceptibility to pneumococcal pneumonia
Tabeling, C., Wienhold, S.-M., Birnhuber, A., Brack, M. C., Nouailles, G., Kershaw, O., Firsching, T. C., Gruber, A. D., Lienau, J., Marsh, L. M., et al. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00505.2020 · Cited by 15
Serum IL-36 cytokines levels in idiopathic pulmonary fibrosis and connective tissue disease-associated interstitial lung diseases
Zhang, Q., Guo, L., Song, X., Lv, C., Tang, P., Li, Y., Ding, Q., & Li, M. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.02.015 · Cited by 15
Ongoing Clinical Trials in Aging-Related Tissue Fibrosis and New Findings Related to AhR Pathways
Yu, H., Feng, Z., Lin, W., Yang, K., Liu, R., Li, J., Liu, X., Pei, M., & Yang, H. (2022) · Aging and Disease · doi:10.14336/ad.2021.1105 · Cited by 16
Epoxyeicosatrienoic Acids Inhibit the Activation of Murine Fibroblasts by Blocking the TGF‐β1‐Smad2/3 Signaling in a PPARγ‐Dependent Manner
Tao, J., Liu, T., Zhang, C., Zu, C., Yang, H., Liu, Y., Yang, J., Zhou, Y., & Guan, C. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7265486 · Cited by 15
Design, synthesis, and biological evaluation of indolin-2-one derivatives as novel cyclin-dependent protein kinase 8 (CDK8) inhibitors
Hsu, J., Hsu, K., Sun, C., Chou, C.-H., Lin, T. E., Sung, T.-Y., Tseng, H.-J., Yen, S., Yang, C., & Huang, W. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114258 · Cited by 15
Sparganii Rhizoma alleviates pulmonary fibrosis by inhibiting fibroblasts differentiation and epithelial-mesenchymal transition mediated by TGF-β1/ Smad2/3 pathway
Liu, J., Gao, D., Ding, Q., Zhang, B., Zhu, W., & Shi, Y. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116305 · Cited by 15
Mesenchymal stem cells and pulmonary fibrosis: a bibliometric and visualization analysis of literature published between 2002 and 2021
Yang, Y., Chen, Y., Liu, Y., Ning, Z.-D., Zhang, Z., Zhang, Y., Xu, K., & Zhang, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1136761 · Cited by 15
Pirfenidone and nintedanib attenuate pulmonary fibrosis in mice by inhibiting the expression of JAK2
Yang, Y., Wang, X., & Zhang, J. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-23-1057 · Cited by 17
Transglutaminase 2 in diabetes mellitus: Unraveling its multifaceted role and therapeutic implications for vascular complications
Ha, K. (2024) · Theranostics · doi:10.7150/thno.95742 · Cited by 15
The incidence of acute exacerbation of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Wang, Y., Ji, Z., Xu, B., Li, S., & Xie, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-71845-x · Cited by 18
Epigenetic silencing of SOD2 exacerbates mitochondrial oxidative stress and promotes pulmonary fibrosis
Wang, X.-C., Zhang, Y.-S., Ling, H., You, J.-B., Cheng, J., Liu, Z., Liu, Z., Lin, L.-C., Mao, S., Liu, P., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.04.034 · Cited by 16
Small airway dysfunction in Chinese patients with idiopathic pulmonary fibrosis
Zhang, X., Xie, B., Ban, C., Ren, Y., Ye, Q., Zhu, M., Liu, Y., Zhang, S., Geng, J., Jiang, D., et al. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-02089-6 · Cited by 15
Yiqi Huayu decoction alleviates bleomycin-induced pulmonary fibrosis in rats by inhibiting senescence
Zuo, B., Zuo, L., Du, X., Yuan, S., Xuan, C., Zhang, Y., Chen, Z., & Cao, W.-F. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1033919 · Cited by 15
AhR Mediated Activation of Pro-Inflammatory Response of RAW 264.7 Cells Modulate the Epithelial-Mesenchymal Transition
Selvam, P., Cheng, C.-M., Dahms‬, H.-U., Ponnusamy, V. K., & Sun, Y. (2022) · Toxics · doi:10.3390/toxics10110642 · Cited by 15
Effect of M6A regulators on diagnosis, subtype classification, prognosis and novel therapeutic target development of idiopathic pulmonary fibrosis
Huang, G., Huang, S., & Cui, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.993567 · Cited by 15

Authors: Richeldi, L., Collard, H. R., & Jones, M. G.
Affiliations: Università Cattolica del Sacro Cuore (IT)
University of California, San Francisco (US)
National Institute for Health and Care Research (GB)
Corresponding author: Richeldi, Luca
ORCID: Richeldi, Luca
Collard, Harold R
Jones, Mark G
Venue: The Lancet
Publisher: Elsevier BV
Published: 2017-05
Volume: 389
Issue: 10082
Pages: 1941-1952
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(17)30866-8
OpenAlex: W2599075603
Cited by: 2,020
References: 143
Citations by year: 2026: 202 · 2025: 317 · 2024: 338 · 2023: 293 · 2022: 273 · 2021: 233 · 2020: 167 · 2019: 94 · 2018: 76 · 2017: 22
FWCI: 17.97
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
ePrints Soton (University of Southampton) (acceptedVersion)
Funders: National Institute for Health and Care Research (CL-2016-26-004)
Topics: Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
Keywords: idiopathic pulmonary fibrosis, pulmonary fibrosis, pathophysiology, extracellular matrix, alveolar architecture, disease-modifying therapy, diagnosis, treatment options, respiratory failure
MeSH terms: Humans, Idiopathic Pulmonary Fibrosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Idiopathic pulmonary fibrosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks